Pediatric Oncology

Pediatric Oncology Flow cytometric detection of Acute Lymphoblastic Leukemia in CSF and its role in predicting survival and neurotoxicity in pediatrics at King Abdulaziz Medical City in Jeddah, Saudi Arabia – A retrospective study
Saher Al-wafi • Dania Monagel • Sami AlThubaiti • Ibrahim Beshawri • Mumen Halabi • Fuad Huwait • Amr Garout
doi.org/10.69690/ODMJ-018-0425-2196
Pediatric Oncology Pediatric Hodgkin Lymphoma: Real World Data Over 15 Years from a Regional Cancer Centre in South India
Amrit Kaur • Jyothi M • Prakruthi Kaushik • Pooja Gujjal Chebbi • Nuthan Kumar • Avinash Thumallapalli • Aruna Kumari • Appaji L • Arun Kumar
doi.org/10.69690/ODMJ-018-0425-2198
Pediatric Oncology Financial Costs of Pediatric Cancer Management in Africa: Systematic Review and Meta-Analysis
Mwanvua Ngongo Laetitia • Koba Mjumbe
doi.org/10.69690/ODMJ-018-0425-2179
Pediatric Oncology Paediatric Rhabdomyosarcoma: 15-Year Experience From A Regional Cancer Centre In South India
Nishkala Rao • Jyothi M • Prakruthi Kaushik • Pooja Chebbi • Nuthan Kumar • Avinash T • Padma M • Arunakumari BS • Appaji L • Arunkumar AR
doi.org/10.69690/ODMJ-018-0425-2176
Pediatric Oncology Early Experience Using the Cog ARET0321 Protocol for the Treatment of International Retinoblastoma Staging System (IRSS) 3 in a Resource-Limited Setting
Juan Paolo Torres • Kaira Monique Osmeña • Joliza Patricia Cañeba • Gary John Mercado • Paulita Pamela Astudillo • Nonette Cupino • Catherine Lam • Ana Patricia Alcasabas
doi.org/10.69690/ODMJ-018-0425-2163
Pediatric Oncology Genetic testing for cancer predisposition syndromes in pediatric oncology: A single center experience
Maria Kurnikova • Anastasiya Salomatina • Yulia Mareeva • Maria Skvortsova • Natalia Klipinina • Elena Raykina • Liudmila Yasko
doi.org/10.69690/ODMJ-018-0425-2162
Pediatric Oncology CD19 Chimeric Antigen Receptor (CAR) T – Cell therapy with Tisagenlecleucel in Children with B-Cell Acute Lymphoblastic Leukemia: Preliminary Findings from a Tertiary Care Center
Nada Alshaikh • Rodaina Abujoub • Rimaz Mustafa • Shahbaz Memon • Ahmed Mahdi Yousif • Sami AlThubaiti • Mohammed Essa
doi.org/10.69690/ODMJ-018-0425-2157
Pediatric Oncology GLI1-Altered Mesenchymal Tumors in Pediatric Patients: A Clinical, Morphological and Molecular Analysis of Four Cases
Ilya Sidorov • Anastasia Sharlay • Vitaly Roshchin • Alexander Druy • Nina Bogatyreva • Garik Sagoyan • Dmitry Konovalov
doi.org/10.69690/ODMJ-018-0425-2150
Pediatric Oncology The Prevalence and Associated Risk Factors for Neonatal Thrombocytopenia Among Newborns Admitted to the Neonatal Intensive Care Unit
Hussain AlGhadeer • Rahmah A. Aldhahi
doi.org/10.69690/ODMJ-018-0425-2148
Pediatric Oncology Possibilities of Using the Systemic Immune-Inflammation Index in the Diagnosis, Treatment, and Prognosis of Pediatric Patients with Hodgkin’s Lymphoma During Puberty
Daniil Dzhavadov • Elena Frantsiyants • Valeria Bandovkina • Yulia Kozel • Daria Yurchenko • Olga Popovyan
doi.org/10.69690/ODMJ-018-0425-2131
Pediatric Oncology Referral Patterns, Time-To-Diagnosis (TTD), and Time-To-Treatment Initiation (TTI) in Children with Cancer: Experience from a Tertiary Care Center, King Faisal Specialist Hospital and Research Centre , Madinah, Saudi Arabia
Afshan Ashraf Aziz • Mohamed Elsaid • Viqaruddin Mohammed • Muhammad Rahil Khan • Mohammed Abdelgalil Hossieny • Mosfer Almalki • Zaib Unnissa Asif • Mashael Saud Alrashidi • Febe Valerie Belasoto Lacson • Noufah Alrashidi • Muhammad Saghir Khan
doi.org/10.69690/ODMJ-018-0425-2129
Pediatric Oncology Vulnerable and Exposed: Tuberculosis in Pediatric oncology patients- Insights from Tertiary Care Hospital in Karachi, Pakistan
Ammara Hameed • Fahad Mumtaz • Uzma Imam • Wajid Hussain
doi.org/10.69690/ODMJ-018-0425-2128